The drug wholesaler’s CVC fund will have up to $39.3m in capital, and will be led by Suzuken's head of corporate strategy, Yuichi Yamamoto.
Suzuken, the Japan-based pharmaceutical wholesaler, is set to launch a corporate venture capital (CVC) fund in July to invest in healthcare technology developers.
The fund will have capital of up to ¥5bn ($39.3m) and will be funded by a capital call scheme through Suzuken Investment, a subsidiary which will be overseen by the firm’s head of corporate strategy, Yuichi Yamamoto.
Suzuken’s fund will be the latest in what is becoming one of the most active corporate venturing ecosystems globally, as…
